|
ARTL Artelo Biosciences Inc 1621221 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-2,958,000.00 |
| Balance Sheet |
|
Current Assets
|
$10,421,000.00 |
|
Assets
|
$12,518,000.00 |
|
Current Liabilities
|
$5,828,000.00 |
|
Liabilities
|
$5,846,000.00 |
|
Equity
|
$6,672,000.00 |
|
Shares Out
|
673008.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,191,000.00 |
|
Investing Cash Flow
|
$-62,000.00 |
| Market Analysis |
Market Cap
|
$511,486.08 |
|
Price
|
$0.77 |
|
BVPS
|
9.91 |
|
PB
|
0.08 |
|
EPS
|
-4.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:47 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ARTL documents filed with the SEC.
ARTL Filings
Clear
